FDA.reportPublic FDA data

NDC 66689-031-01 - Metoclopramide Hydrochloride

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
66689-031
Requested NDC
66689-031-01
Package NDCs from labels
66689-031-01, 66689-031-50
Manufacturer
VistaPharm, LLC
Effective date
2024-07-11
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Metoclopramide Hydrochloride - VistaPharm, LLCVistaPharm, LLC2024-07-11HUMAN PRESCRIPTION DRUG LABEL
National Council for Prescription Drug Programs indexing - billing unitNational Council for Prescription Drug Programs2013-02-13Indexing - Billing Unit

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
66689-031-502024-01-30C16284748780-11030e365-276c-111a-e063-dadaa90a10e2METOCLOPRAMIDE ORAL SOLUTION, USP 5 mg/5 mL

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
66689-031-01ML - Milliliter66689-03121c6cdb2-83f7-412d-beb1-8dd49b4ba7f312013-02-13
66689-031-50ML - Milliliter66689-0317ec00a6a-fe58-4173-80a2-fd83172446f112012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
Metoclopramide HydrochlorideACTIVE INGREDIENTW1792A2RVDMETOCLOPRAMIDE HYDROCHLORIDE SOLUTION [VISTAPHARM INC.]5
MetoclopramideACTIVE MOIETYL4YEB44I46METOCLOPRAMIDE HYDROCHLORIDE SOLUTION [VISTAPHARM INC.]5
ANHYDROUS CITRIC ACIDINACTIVE INGREDIENTXF417D3PSLMETOCLOPRAMIDE HYDROCHLORIDE SOLUTION [VISTAPHARM INC.]5
FD&C YELLOW NO. 6INACTIVE INGREDIENTH77VEI93A8METOCLOPRAMIDE HYDROCHLORIDE SOLUTION [VISTAPHARM INC.]5
GLYCERININACTIVE INGREDIENTPDC6A3C0OXMETOCLOPRAMIDE HYDROCHLORIDE SOLUTION [VISTAPHARM INC.]5
METHYLPARABENINACTIVE INGREDIENTA2I8C7HI9TMETOCLOPRAMIDE HYDROCHLORIDE SOLUTION [VISTAPHARM INC.]5
SORBITOLINACTIVE INGREDIENT506T60A25RMETOCLOPRAMIDE HYDROCHLORIDE SOLUTION [VISTAPHARM INC.]5
WATERINACTIVE INGREDIENT059QF0KO0RMETOCLOPRAMIDE HYDROCHLORIDE SOLUTION [VISTAPHARM INC.]5

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 32 of 32 · 626 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Homeoplex DGLYCERINUM, PHYTOLACCA DECANDRA, TARAXACUM OFFICINALE, ARSENICUM ALBUM, NITRICUM ACIDUM, NUX VOMICA, PETROLEUM, PHOSPHORICUM ACIDUM, PHOSPHORUS, ACETYLSALICYLICUM ACIDUM, GLONOINUM, INSULINUM (SUIS), LITHIUM CARBONICUM, THYROIDINUM (SUIS), SALICYLICUM ACIDUM, ADRENOCORTICOTROPHIN, CORTISONE ACETICUM, EUGENOL, STEARYL ALCOHOL, XYLITOL, FOLLICULINUM, BENZOICUM ACIDUM, CHLORINUM, POTASSIUM SORBATE, SORBITOL, RESORCINUM, BENZYL ALCOHOL, LACTICUM ACIDUM, ISOPROPYL PALMITATE, BORICUM ACIDUM, ACETICUM ACIDUM,Supplement Clinic, LLC.cd6b48ab-3566-484d-8deb-15ef6f8e7e8f2017-11-01WarningsExact identifier
unii: PDC6A3C0OX
unii: 506T60A25R
Sterile WaterWATERBaxter Healthcare Corporationef3e79c5-3f58-4b36-a296-64b7d9a651c12017-10-17Warnings, Adverse reactionsExact identifier
unii: 059QF0KO0R
FIND BICHON CLEANSING MASKGLYCERINPioom Cosmetic Co.,ltd50b7db48-7b55-6df4-e054-00144ff88e882017-05-30WarningsExact identifier
unii: PDC6A3C0OX
Eye WashWATERCVS Pharmacy049cee29-7ec2-4d5b-8308-f522acde43a72017-03-29WarningsExact identifier
unii: 059QF0KO0R
Sterile WaterWATERBaxter Healthcare Company210dc9ab-d6ca-4552-ac19-1be17792d2902016-05-31Warnings, Adverse reactionsExact identifier
unii: 059QF0KO0R
CPDA-1ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINEFenwal, Inc.051f7347-5a76-4664-8fe2-e61b3dfcb0e42014-08-27Exact identifier
unii: XF417D3PSL

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.